OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Open-label placebo for chronic low back pain: a 5-year follow-up
Cláudia Carvalho, Maria Pais, Lidia Cunha, et al.
Pain (2020) Vol. 162, Iss. 5, pp. 1521-1527
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome
Samuel Nurko, Miguel Saps, Joe Kossowsky, et al.
JAMA Pediatrics (2022) Vol. 176, Iss. 4, pp. 349-349
Open Access | Times Cited: 34

Placebo effects in osteoarthritis: implications for treatment and drug development
Tuhina Neogi, Luana Colloca
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 10, pp. 613-626
Open Access | Times Cited: 21

Open-Label Placebo Injection for Chronic Back Pain With Functional Neuroimaging
Yoni K. Ashar, Michael Sun, Karen Knight, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2432427-e2432427
Open Access | Times Cited: 6

Is It All in Your Head? Placebo Effects in Concussion Prevention
James M. Smoliga, Chris Bleakley, Alan J. Pearce
Sports Medicine (2025)
Closed Access

An update on non-pharmacological interventions for pain relief
Yang Wang, Rachel V. Aaron, Nadine Attal, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101940-101940
Open Access

Placebos in clinical care: a suggestion beyond the evidence
Christopher G. Maher, Adrian C. Traeger, Christina Abdel Shaheed, et al.
The Medical Journal of Australia (2021) Vol. 215, Iss. 6, pp. 252-252
Open Access | Times Cited: 22

Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder
Annabelle M. Belcher, Thomas O. Cole, Ebonie Massey, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e237099-e237099
Open Access | Times Cited: 8

The Placebo Effect in Psychosis: Why It Matters and How to Measure It
Emily Hird, Kelly Diederen, Stefan Leucht, et al.
Biological Psychiatry Global Open Science (2023) Vol. 3, Iss. 4, pp. 605-613
Open Access | Times Cited: 7

Can observational learning reinforce open-label placebo hypoalgesia?
Justyna Brączyk, Przemysław Bąbel
Pain (2024) Vol. 165, Iss. 7, pp. 1605-1612
Open Access | Times Cited: 2

A Fictionalist Account of Open-Label Placebo
Doug Hardman
The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine (2024) Vol. 49, Iss. 3, pp. 246-256
Open Access | Times Cited: 2

No long-term effects after a 3-week open-label placebo treatment for chronic low back pain: a 3-year follow-up of a randomized controlled trial
Julian Kleine‐Borgmann, Tim-Niklas Dietz, Katharina Schmidt, et al.
Pain (2022) Vol. 164, Iss. 3, pp. 645-652
Open Access | Times Cited: 12

Can placebos reduce intrusive memories?
Tobias Kube, Irving Kirsch, Julia A. Glombiewski, et al.
Behaviour Research and Therapy (2022) Vol. 158, pp. 104197-104197
Closed Access | Times Cited: 10

Open-Label Placebo Administration Decreases Pain in Elderly Patients With Symptomatic Knee Osteoarthritis – A Randomized Controlled Trial
Elisabeth Olliges, Sabine Stroppe, Anja Haile, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 8

What can we learn from long-term studies on chronic low back pain? A scoping review
Alisa L. Dutmer, Remko Soer, André Wolff, et al.
European Spine Journal (2022) Vol. 31, Iss. 4, pp. 901-916
Open Access | Times Cited: 7

Remotely Provided Open-Label Placebo Reduces Frequency of and Impairment by Allergic Symptoms
Tobias Kube, Irving Kirsch, Julia A. Glombiewski, et al.
Psychosomatic Medicine (2022) Vol. 84, Iss. 9, pp. 997-1005
Open Access | Times Cited: 7

A Conversation with … Ted J. Kaptchuk, Expert in Placebo Effects
Seth S. Leopold
Clinical Orthopaedics and Related Research (2021) Vol. 479, Iss. 8, pp. 1645-1650
Open Access | Times Cited: 9

Placebo, nocebo: Believing in the field of medicine
Karin Meißner
Frontiers in Pain Research (2022) Vol. 3
Open Access | Times Cited: 5

Predicting placebo analgesia in patients with chronic pain using natural language processing: a preliminary validation study
Paulo Branco, Sara Berger, Taha Abdullah, et al.
Pain (2022) Vol. 164, Iss. 5, pp. 1078-1086
Open Access | Times Cited: 5

Hypnosis and Academia from an Iberian Perspective
Pedro Rodrigues Ribeiro
Springer eBooks (2023), pp. 125-142
Closed Access | Times Cited: 2

Preserving the placebo effect after disclosure: A new perspective on non‐deceptive placebos
Mehran Emadi Andani, Diletta Barbiani, M. Bonetto, et al.
British Journal of Psychology (2024) Vol. 115, Iss. 3, pp. 437-453
Open Access

What should constitute a control condition in psychedelic drug trials?
Luana Colloca, Maurizio Fava
Nature Mental Health (2024)
Closed Access

Side effects following administration of open-placebos: A randomized controlled trial
Kate Faasse, Chiara Gasteiger, Anna Borgmann, et al.
Journal of Psychosomatic Research (2024) Vol. 189, pp. 112028-112028
Open Access

Page 1 - Next Page

Scroll to top